Increasing apoA-I production as a target for CHD risk reduction

作者: Stefan P.J. Dullens , Jogchum Plat , Ronald P. Mensink

DOI: 10.1016/J.NUMECD.2007.05.001

关键词:

摘要: Dyslipidemia leading to coronary heart diseases (CHD) enables venues prevent or treat CHD by other strategies than only lowering serum LDL cholesterol (LDL-C) concentrations, which is currently the most frequently targeted change. Unlike LDL-C, elevated high-density lipoprotein (HDL-C) concentrations may protect against development of as demonstrated in numerous large-scale epidemiological studies. In this review we describe that besides elevating HDL-C increasing alpha-HDL particles, approaches elevate pre-beta HDL particle seems more attractive. Besides infusion apoA-I(Milano), using apoA-I mimetics, delipidation de novo production be a suitable target functionally increase concentrations. Therefore, detailed description molecular pathways underlying synthesis and secretion, completed with an overview known effects pharmacological nutritional compounds on will presented. This knowledge ultimately applied developing dietary intervention consequently lower risk.

参考文章(94)
B S Horowitz, I J Goldberg, J Merab, T M Vanni, R Ramakrishnan, H N Ginsberg, Increased plasma and renal clearance of an exchangeable pool of apolipoprotein A-I in subjects with low levels of high density lipoprotein cholesterol Journal of Clinical Investigation. ,vol. 91, pp. 1743- 1752 ,(1993) , 10.1172/JCI116384
George Miltiadous, Marilena Hatzivassiliou, Evagelos Liberopoulos, Eleni Bairaktari, Alexandros Tselepis, Marios Cariolou, Moses Elisaf, Gene polymorphisms affecting HDL-cholesterol levels in the normolipidemic population Nutrition Metabolism and Cardiovascular Diseases. ,vol. 15, pp. 219- 224 ,(2005) , 10.1016/J.NUMECD.2004.09.004
Jean-François Mauger, Patrick Couture, Marie-Eve Paradis, Benoît Lamarche, Comparison of the impact of atorvastatin and simvastatin on apoA-I kinetics in men. Atherosclerosis. ,vol. 178, pp. 157- 163 ,(2005) , 10.1016/J.ATHEROSCLEROSIS.2004.06.022
Kulwara Meksawan, David R. Pendergast, John J. Leddy, Melanie Mason, Peter J. Horvath, Atif B. Awad, Effect of Low and High Fat Diets on Nutrient Intakes and Selected Cardiovascular Risk Factors in Sedentary Men and Women Journal of The American College of Nutrition. ,vol. 23, pp. 131- 140 ,(2004) , 10.1080/07315724.2004.10719353
Patrick Benoit, Florence Emmanuel, Jean Michel Caillaud, Laurent Bassinet, Graciela Castro, Pierre Gallix, Jean Charles Fruchart, Didier Branellec, Patrice Denèfle, Nicolas Duverger, Somatic Gene Transfer of Human ApoA-I Inhibits Atherosclerosis Progression in Mouse Models Circulation. ,vol. 99, pp. 105- 110 ,(1999) , 10.1161/01.CIR.99.1.105
James D. Otvos, Dorothea Collins, David S. Freedman, Irina Shalaurova, Ernst J. Schaefer, Judith R. McNamara, Hanna E. Bloomfield, Sander J. Robins, Low-Density Lipoprotein and High-Density Lipoprotein Particle Subclasses Predict Coronary Events and Are Favorably Changed by Gemfibrozil Therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial Circulation. ,vol. 113, pp. 1556- 1563 ,(2006) , 10.1161/CIRCULATIONAHA.105.565135
Jerzy-Roch Nofer, Beate Kehrel, Manfred Fobker, Bodo Levkau, Gerd Assmann, Arnold von Eckardstein, HDL and arteriosclerosis: beyond reverse cholesterol transport. Atherosclerosis. ,vol. 161, pp. 1- 16 ,(2002) , 10.1016/S0021-9150(01)00651-7
Steven E. Nissen, Taro Tsunoda, E. Murat Tuzcu, Paul Schoenhagen, Christopher J. Cooper, Muhammad Yasin, Gregory M. Eaton, Michael A. Lauer, W. Scott Sheldon, Cindy L. Grines, Stephen Halpern, Tim Crowe, James C. Blankenship, Richard Kerensky, Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA. ,vol. 290, pp. 2292- 2300 ,(2003) , 10.1001/JAMA.290.17.2292
Tiny Hoekstra, Johanna M. Geleijnse, Evert G. Schouten, Frans J. Kok, Cornelis Kluft, Relationship of C-reactive protein with components of the metabolic syndrome in normal-weight and overweight elderly Nutrition Metabolism and Cardiovascular Diseases. ,vol. 15, pp. 270- 278 ,(2005) , 10.1016/J.NUMECD.2005.01.004
Federica Basso, Lita Freeman, Catherine L. Knapper, Alan Remaley, John Stonik, Edward B. Neufeld, Terese Tansey, Marcelo J. A. Amar, Jamila Fruchart-Najib, Nicholas Duverger, Silvia Santamarina-Fojo, H. Bryan Brewer, Role of the hepatic ABCA1 transporter in modulating intrahepatic cholesterol and plasma HDL cholesterol concentrations. Journal of Lipid Research. ,vol. 44, pp. 296- 302 ,(2003) , 10.1194/JLR.M200414-JLR200